Symbols / CNCE
CNCE Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- This once-hot cancer-detection company’s stock got cut in half after a failed trial - MarketWatch Fri, 20 Feb 2026 21
- Top Cancer Stocks for 2026 and How to Invest - The Motley Fool hu, 12 Feb 2026 08
- Moderna Stock Soars. Why a Cancer Vaccine Study Has Sparked a Rally. - Barron's hu, 22 Jan 2026 08
- Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here - CNBC hu, 30 Oct 2025 07
- GSK cancer, HIV drug sales lift 2025 outlook in boost for shares - Reuters Wed, 29 Oct 2025 07
- Assessing ImmunityBio After Recent Cancer Immunotherapy Headlines and Ongoing Stock Volatility - Yahoo Finance Mon, 01 Dec 2025 08
- Bayer Shares Surge as Partner Forecasts Sales Growth for Prostate-Cancer Drug - WSJ Wed, 14 Jan 2026 08
- Celcuity stock rallies on Phase III breast cancer trial progress - Clinical Trials Arena Mon, 28 Jul 2025 07
- Why the Stock Price of This Cancer Screening Company Soared 17% Thursday - Investopedia hu, 20 Nov 2025 08
- Investors whale on Cardiff, sinking stock after seeing updated colorectal cancer data - Fierce Biotech Wed, 30 Jul 2025 07
- This Medical Stock With Blockbuster Cancer Drug Clears Entry Amid 923% Earnings Growth - Investor's Business Daily Fri, 15 Aug 2025 07
- King Charles Shares ‘Good News’ About His Cancer Treatment in Video Message - The New York Times Fri, 12 Dec 2025 08
- Nuvation Bio stock climbs 16.67% on FDA approval of lung cancer drug - Mugglehead Investment Magazine Fri, 05 Sep 2025 07
- 3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment - Yahoo Finance hu, 18 Dec 2025 08
- Roche oral drug shown to keep breast cancer at bay, boosting shares - Reuters ue, 18 Nov 2025 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for CNCE
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|